Global patterns of cervical cancer incidence and mortality: updated statistics and an overview of temporal trends from 2003 to 2017
Peer-Reviewed Publication
Updates every hour. Last Updated: 29-Apr-2025 11:08 ET (29-Apr-2025 15:08 GMT/UTC)
Global disparities exist in the burden of cervical cancer. Only 11 out of the 185 countries and regions reported an age-standardized incidence rates (ASIR) lower than the World Health Organization’s target as established by the Cervical Cancer Elimination Initiative. Human Development Index (HDI) was negatively correlated with ASIR and age-standardized mortality rates (ASMR) of cervical cancer. The disease's burden is marked by clear socioeconomic disparities, underscoring the need to develop and evaluate targeted cervical cancer prevention and control strategies for specific regions.
Researchers from the University of Birmingham have uncovered answers that provide the detail to explain two specific DNA repair processes that have long been in question. The publication of two papers demonstrates how work led by laboratories from the University of Birmingham has made strides in understanding how the repair process is correctly orchestrated.
The powerful potential of nano technologies and AI to detect oral cancer earlier and more accurately have been revealed by a University of Otago – Ōtākou Whakaihu Waka study.
https://doi.org/10.1016/j.apsb.2024.12.018
This new article publication from Acta Pharmaceutica Sinica B, discusses how disrupting calcium homeostasis and glycometabolism in engineered lipid-based pharmaceuticals propel cancer immunogenic death.
New research has revealed that Schistosoma haematobium (S. haematobium), a parasitic infection affecting millions globally, can trigger cancer-related gene activity in the cervical lining, with changes becoming even more pronounced after treatment.1 Presented today at ESCMID Global 2025, this pivotal study sheds new light on how this often-overlooked parasitic disease may contribute to cervical cancer risk at the molecular level.
Natasha Sheybani is focusing her research on defeating metastatic breast cancer.